Clinical pharmacy services in cancer patients with hypertension-Reference-Cited by-同舟云学术

Clinical pharmacy services in cancer patients with hypertension

Published:2024-01-01 Issue:1 Volume:26 Page:175-178
ISSN:1765-2839
Container-title:Oncologie
language:en
Short-container-title:

Author:

Tezcan Songul¹,Yılmaz Feyza Nur²

Affiliation:

1. Department of Clinical Pharmacy, Faculty of Pharmacy , Marmara University , Istanbul , Türkiye

2. Clinical Pharmacy, Institute of Health Sciences, Marmara University , Istanbul , Türkiye

Abstract

Abstract Clinical pharmacy services aim to ensure the rational use of drugs and resolve disease/health conditions with a multidisciplinary approach. Pharmaceutical care plans need to be created to effectively provide clinical pharmacy services in the treatment of hypertension which is one of the common chronic diseases in cancer patients. In this mini-review, we examine which drugs can cause or worsen hypertension in patients receiving cancer treatment, potential drug-drug interactions between drugs used in cancer treatment and antihypertensive drugs, pharmacological and clinical studies for the treatment of hypertension in patients with hypertension before cancer diagnosis or newly diagnosed hypertension due to cancer treatment. Non-pharmacological treatment approaches are presented. We think that our study will be a resource that can be used to solve possible drug-related problems in the practice.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/oncologie-2023-0514/pdf

Reference11 articles.

1. Kibret, AA, Aragie, H, Belay, DG, Molla, MD, Teferi, ET, Melese, EB, et al.. Hypertension and its associated factors among cancer patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: Hospital-Based Cross-Sectional Study. J Multidiscip Healthc 2022;15:793–803. https://doi.org/10.2147/jmdh.s352114.

2. Osoro, I, Amir, M, Vohra, M, Sharma, A. Pharmacist interventions in minimizing drug related problems in diabetes with co-existing hypertension: a five-year overview and ground report from India. Int J Publ Health 2023;68:1605808. https://doi.org/10.3389/ijph.2023.1605808.

3. Pandey, S, Kalaria, A, Jhaveri, KD, Herrmann, SM, Kim, AS. Management of hypertension in patients with cancer: challenges and considerations. Clin Kidney J 2023;16:2336–48. https://doi.org/10.1093/ckj/sfad195.

4. Wagner, TD, Jones, MC, Salgado, TM, Dixon, DL. Pharmacist’s role in hypertension management: a review of key randomized controlled trials. J Hum Hypertens 2020;34:487–94. https://doi.org/10.1038/s41371-020-0331-7.

5. Williams, B, Mancia, G, Spiering, W, Agabiti Rosei, E, Azizi, M, Burnier, M, et al.. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension [published correction appears in J Hypertens. 2019 Jan;37(1):226]. J Hypertens 2018;36:1953–2041. https://doi.org/10.1097/HJH.0000000000001940.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FSRM-DDIE : few-shot learning methods based on relation metrics for the prediction of drug-drug interaction events;Applied Intelligence;2024-09-10